Caris Life SciencesCAI
那斯達克 · USD
15.78
+0.22
(+1.41%)
盤中 07/22 01:26 (UTC+8)
07/22 01:26 (UTC+8)
Caris Life SciencesCAI
15.78
+0.22
(+1.41%)
財務數據
損益表
- 0.86
- 1.01
- 0.81
- 1.00
- -
- 1.21
- 1.81
- 2.17
- 2.93
- 2.16
- 6.06
- 17.66
- -
- 24.01
- -
- -
- 50.02
- 19.53
- 35.07
- -26.19
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q2 | 2024/Q1 | 2021/Q3 | 2021/Q2 | |
營業收入淨額 | 216,174 | 292,886 | 216,833 | 181,399 | 120,915 | - | 100,049 | 80,677 | 100,827 | 85,695 |
營業成本 | 74,826 | 71,972 | 69,328 | 67,713 | 63,852 | - | 62,495 | 54,563 | - | - |
營業毛利 | 141,348 | 220,914 | 147,505 | 113,686 | 57,063 | - | 37,554 | 26,114 | 100,827 | 85,695 |
營業費用 | 136,066 | 132,503 | 114,863 | 131,675 | 115,014 | - | 104,565 | 118,339 | 47,576 | 41,882 |
研發費用 | 31,315 | 31,845 | 21,625 | 25,048 | 23,066 | - | 24,787 | 34,376 | - | - |
推銷及管理費用 | 104,751 | 100,658 | 93,238 | 106,627 | 91,948 | - | 79,778 | 83,963 | 14,898 | 12,612 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | 32,678 | 29,270 |
營業利益 | 5,282 | 88,411 | 32,642 | -17,988 | -57,952 | - | -67,011 | -92,225 | 66,443 | 50,839 |
其他收入及費用 | 6,883 | 4,902 | 5,190 | -34,593 | -31,847 | - | - | - | 13,040 | 7,100 |
利息費用 | 12,809 | 11,356 | 13,507 | 19,208 | 12,782 | - | 13,674 | 9,290 | 11,458 | 11,114 |
稅前純益 | -644 | 81,957 | 24,325 | -71,789 | -102,581 | - | -66,186 | -111,028 | 54,833 | 39,799 |
所得稅 | -134 | - | - | - | - | - | - | - | 3,678 | 1,856 |
稅後純益 | -510 | 81,957 | 24,325 | -71,789 | -102,581 | - | -66,186 | -111,028 | 51,155 | 37,943 |
基本每股稅後盈餘(元) | - | 0.29 | 0.09 | -7.97 | -0.46 | - | -0.35 | -0.53 | 2.82 | 2.07 |
稀釋每股稅後盈餘(元) | - | 1.61 | 7.97 | -9.23 | -3.57 | - | -0.35 | -0.53 | 2.79 | 2.05 |
基本平均股數(千股) | 282562.00 | 282215.00 | 282099.00 | 64918.00 | 277932.00 | - | 254788.00 | 254788.00 | 17337.00 | 17281.00 |
稀釋平均股數(千股) | 282562.00 | 296089.00 | 297211.00 | 64918.00 | 277932.00 | - | 254788.00 | 254788.00 | 17531.00 | 17479.00 |
還原基本每股稅後盈餘(元) | - | 0.29 | 0.09 | -7.97 | -0.46 | - | -0.35 | -0.53 | 2.82 | 2.07 |
還原稀釋每股稅後盈餘(元) | - | 1.61 | 7.97 | -9.23 | -3.57 | - | -0.35 | -0.53 | 2.79 | 2.05 |
還原基本平均股數(千股) | 282,562 | 282,215 | 282,099 | 64,918 | 277,932 | - | 254,788 | 254,788 | 17,337 | 17,281 |
還原稀釋平均股數(千股) | 282,562 | 296,089 | 297,211 | 64,918 | 277,932 | - | 254,788 | 254,788 | 17,531 | 17,479 |
EBITDA(千元) | 19,854 | 98,209 | 45,165 | -38,417 | -80,809 | - | -40,902 | -84,033 | 99,997 | 81,191 |